ACG ADVOCACY for GENENTECH INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 14, 2021 | $40,000 | Replaced |
| 4th Quarter - Termination | Feb 12, 2021 | $40,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade Negotiations. Trade Policy Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA COLARULLI | — |
| CHRIS ISRAEL | — |
Copyright/Patent/Trademark CPT
General IP Issues. Patent Litigation Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA COLARULLI | Director, Government Affairs PTO |
| CHRIS ISRAEL | U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce. |
Pharmacy PHA
Drug Pricing Issues. Public Health Crisis. H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS ISRAEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.